Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Collins

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Nature Genetics|May 26, 2015
Spatial genomic heterogeneity within localized, multifocal prostate cancerPaul C Boutros, Michael Fraser, Nicholas J Harding, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Nature Genetics|May 26, 2015
Spatial genomic heterogeneity within localized, multifocal prostate cancerPaul C Boutros, Michael Fraser, Nicholas J Harding, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Pageof 10